RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-8.24%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.44B
AUM Growth
-$537M
(-14%)
Cap. Flow
+$63.8M
Cap. Flow
% of AUM
1.86%
Top 10 Holdings %
Top 10 Hldgs %
35%
Holding
142
New
7
Increased
68
Reduced
12
Closed
10
Top Buys
| 1 |
Align Technology
ALGN
|
$32.7M |
| 2 |
Humana
HUM
|
$27M |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
$25.6M |
| 4 |
Penumbra
PEN
|
$24.5M |
| 5 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$20.5M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$94M |
| 2 |
Encompass Health
EHC
|
$35.7M |
| 3 |
iRhythm Technologies
IRTC
|
$17.9M |
| 4 |
XENT
Intersect ENT, Inc
XENT
|
$15.4M |
| 5 |
Rigel Pharmaceuticals
RIGL
|
$14.7M |
Sector Composition
| 1 | Healthcare | 96.7% |
| 2 | Consumer Staples | 0.96% |
| 3 | Industrials | 0.47% |
| 4 | Financials | 0.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CERE
26
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $46.7M | 1.36% |
1,767,141
+43,800
| +3% | +$1.16M |
|
|
SWAV
27
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $46M | 1.34% |
240,500
-31,000
| -11% | -$5.93M |
|
28
Baxter International
BAX
$12.1B
| $45.1M | 1.31% |
701,600
-49,100
| -7% | -$3.15M |
|
29
Zai Lab
ZLAB
$3.48B
| $42.2M | 1.23% |
1,215,900
+10,000
| +0.8% | +$347K |
|
30
Ascendis Pharma
ASND
$12.1B
| $39.6M | 1.15% |
425,500
+8,000
| +2% | +$744K |
|
31
DexCom
DXCM
$30.9B
| $35.2M | 1.03% |
472,800
+56,800
| +14% | +$4.23M |
|
|
CVET
32
DELISTED
Covetrus, Inc. Common Stock
CVET
| $34.8M | 1.01% |
1,678,800
+3,800
| +0.2% | +$78.9K |
|
33
Xenon Pharmaceuticals
XENE
$2.99B
| $34.2M | 0.99% |
1,123,604
+281,106
| +33% | +$8.55M |
|
|
NVRO
34
DELISTED
NEVRO CORP.
NVRO
| $33.9M | 0.99% |
773,300
+51,800
| +7% | +$2.27M |
|
35
West Pharmaceutical
WST
$17.9B
| $33.6M | 0.98% |
111,000
+41,750
| +60% | +$12.6M |
|
36
Mirum Pharmaceuticals
MIRM
$3.75B
| $33.4M | 0.97% |
1,717,733
+51,525
| +3% | +$1M |
|
37
Freshpet
FRPT
$2.59B
| $33.1M | 0.96% |
637,600
+45,100
| +8% | +$2.34M |
|
38
Phreesia
PHR
$1.81B
| $32.5M | 0.94% |
1,298,200
+348,200
| +37% | +$8.71M |
|
39
Sarepta Therapeutics
SRPT
$1.98B
| $32.1M | 0.93% |
428,000
| – | – |
|
|
40
iRhythm Technologies
IRTC
$5.67B
| $29.2M | 0.85% |
270,000
-166,000
| -38% | -$17.9M |
|
|
41
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $25.6M | 0.75% |
+200,000
| New | +$25.6M |
|
42
Novavax
NVAX
$1.2B
| $24.4M | 0.71% |
475,100
+26,900
| +6% | +$1.38M |
|
|
ABCM
43
DELISTED
Abcam plc American Depositary Shares
ABCM
| $23.4M | 0.68% |
1,620,500
+187,600
| +13% | +$2.71M |
|
44
Travere Therapeutics
TVTX
$1.75B
| $23.1M | 0.67% |
951,650
| – | – |
|
45
Madrigal Pharmaceuticals
MDGL
$9.7B
| $22.7M | 0.66% |
317,485
+43,985
| +16% | +$3.15M |
|
46
Exact Sciences
EXAS
$9.33B
| $22.6M | 0.66% |
572,700
+2,700
| +0.5% | +$106K |
|
47
BioMarin Pharmaceuticals
BMRN
$11.3B
| $21.9M | 0.64% |
264,500
| – | – |
|
48
CONMED
CNMD
$1.64B
| $21.4M | 0.62% |
223,000
+20,500
| +10% | +$1.96M |
|
49
Dynavax Technologies
DVAX
$1.19B
| $21.2M | 0.62% |
1,681,458
+90,564
| +6% | +$1.14M |
|
|
TPTX
50
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $20.5M | 0.6% |
+271,787
| New | +$20.5M |
|